The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to ...

The Trump administration released a more stringent set of guidelines for approving Covid-19 ... approval, FDA Commissioner Dr. Marty Makary and the agency’s new vaccines chief, Dr. Vinay Prasad ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.

Critics fear that U.S. Department of Health and Human Services chief RFK, Jr., known for his antivaccine views, has picked a ...

U.S. health officials, following recommendations by infectious disease experts, have been urging annual COVID-19 boosters for ...

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for ...